MIR4632

Across TCGA pan-cancer cohorts, MIR4632 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated MIR4632 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher MIR4632 RNA is associated with better overall survival. In most high-consensus cancer types, elevated MIR4632 expression acts as an unfavorable survival marker, although some lineages such as STAD and ESCA show a favorable association.

STAD, DLBC, and OV are the cancer types where MIR4632 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Median	All	0.772	0.638	.002	50	view →
DLBC	OS	Tertile	II,III,IV	0.715	0.978	.002	45	view →
OV	OS	Tertile	IV	0.572	0.818	.007	36	view →
CESC	DFS	Tertile	IV	0.072	0.553	<.001	36	view →
LUSC	OS	Tertile	IV	0.001	0.673	.014	36	view →
THCA	OS	Tertile	III,IV	0.882	0.988	.003	27	view →
PRAD	DFS	Tertile	All	0.545	0.787	.001	18	view →
MESO	OS	Tertile	III,IV	0.261	0.414	.030	18	view →
KIRC	OS	Tertile	All	0.745	0.820	.007	15	view →
KIRP	OS	Tertile	III,IV	0.433	0.785	.035	12	view →
SKCM	DFS	Tertile	IV	0.016	0.541	.008	9	view →
LIHC	DFS	Tertile	III,IV	0.114	0.423	.024	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

MIR4632–STAD (OS)

Open the STAD breakdown →